Amgen gets approval for one (but not another) indication for their new bone drug - Food and Drug Administration experts unanimously voted that Amgen's injectable drug denosumab helps prevent bone …
Today’s Top News in Pharma 070809
Amgen's big win - Amgen's experimental denosumab is more effective than Novartis' blockbuster Zometa in preventing advanced breast cancer from damaging bone, Amgen said in a press release …
Today’s Top (8) in Pharma 050709
This will probably be the last Top Three post for about a week or so, as I head out to Chicago for the SPBT (Society of Pharmaceutical and Biotech Trainers) conference. And there's a bit of backlog …
Pharma News this week (and last)
Roche's MabThera can help extend CLL patients' lives. Meanwhile, surprisingly good results for AZ's lung cancer drug Iressa. But, disappointment for an experimental lung cancer drug being developed by …
Pharma News 10_03
Is Eli Lilly the "mystery suitor" for ImClone? - Eli Lilly & Co. is in advanced talks to buy cancer-drug developer ImClone Systems for $70 a share, or $6.1 billion, The Wall Street Journal …
Pharma News 6_2
A ton of cancer news out of ASCO (American Society of Clinical Oncology). We'll get to those in a minute. First, all the other stuff: Pfizer's Chantix running into heavy weather - Hundreds of …